Nu Skin Enterprises, Inc. Q2 2026 Earnings Recap

Nu Skin’s shares dropped 11.3% following the quarter, reflecting investor disappointment primarily driven by cautious full-year guidance and ongoing challenges in sales force recruitment and leadership development, suggesting deceleration in core business momentum.

Key Takeaways

• Q2 revenue reached approximately $320 million, supported by early growth in the Prysm iO device placements, which increased nearly 30% quarter-over-quarter to over 39,000 units.
• Adjusted EPS landed near the midpoint of the prior range, reflecting focus on profitability despite operational headwinds.
• Sales force recruitment and leadership development remain below levels necessary for sustained growth, limiting channel expansion despite global compensation framework adjustments.
• The company updated full-year revenue and EPS guidance downward, signaling caution about the near-term outlook.
• Continued investment in Prysm iO innovation and emerging markets aims to drive long-term growth but results have yet to translate into immediate top-line acceleration.